Patents by Inventor Stuart A. Fine

Stuart A. Fine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080213400
    Abstract: Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
    Type: Application
    Filed: July 24, 2007
    Publication date: September 4, 2008
    Applicant: Akesis Pharmaceuticals
    Inventors: Stuart A. Fine, Kevin J. Kinsella
  • Publication number: 20080181970
    Abstract: Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
    Type: Application
    Filed: July 24, 2007
    Publication date: July 31, 2008
    Applicant: Akesis Pharmaceuticals
    Inventors: Stuart A. Fine, Kevin J. Kinsella
  • Patent number: 6852760
    Abstract: Compositions and methods of using the same for the treatment of diabetes and other disorders of glucose metabolism are provided. Compositions may include an anti-diabetic agent and one or more of a bioavailable source of chromium and vanadium.
    Type: Grant
    Filed: September 17, 1999
    Date of Patent: February 8, 2005
    Assignee: Akesis Pharmaceuticals, Inc.
    Inventors: Stuart A. Fine, Kevin J. Kinsella
  • Patent number: 6376549
    Abstract: Compositions and methods using same for the treatment of diabetes its sequelae and pre-diabetic conditions are provided. Invention compositions include the anti-diabetic agent metformin, and bioavailable sources of one or more of chromium, vanadium and magnesium. Also provided are pharmaceutical agents containing invention compositions and methods for administering such agents.
    Type: Grant
    Filed: September 17, 1998
    Date of Patent: April 23, 2002
    Assignee: Akesis Pharmaceuticals, Inc.
    Inventors: Stuart A. Fine, Kevin J. Kinsella
  • Patent number: 6203819
    Abstract: A daily nutritional supplement and method of administering it to assist in the metabolism of glucose for patients with diabetes and pre-diabetes is disclosed. The supplement preferably includes anchor components of Chromium Polynicotinate and Picolinate, Vanadyl Sulfate, Vitamin E Natural, Standardized Willow Bark (aspirin), and Magnesium Chloride, Citrate, Fumarate, Malate, Glutorate, and Succinate Complex, Folic Acid, and Alpha-Lipoic Acid.
    Type: Grant
    Filed: March 19, 1999
    Date of Patent: March 20, 2001
    Assignee: Akesis Pharmaceuticals, Inc.
    Inventor: Stuart A. Fine
  • Patent number: 5962030
    Abstract: A daily nutritional supplement and method of administering it to assist in the metabolism of glucose for patients with diabetes and pre-diabetes is disclosed. The supplement preferably includes anchor components of Chromium Polynicotinate and Picolinate, Vanadyl Sulfate, Vitamin E Natural, Standardized Willow Bark (aspirin), and Magnesium Chloride, Citrate, Fumarate, Malate, Glutorate, and Succinate Complex, Folic Acid, and Alpha-Lipoic Acid.
    Type: Grant
    Filed: November 5, 1997
    Date of Patent: October 5, 1999
    Assignee: Akesis Pharmaceuticals, Inc.
    Inventor: Stuart A. Fine